Supplementary Materials 1 and 2 from Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Year: 2023
Type: supplementary-materials
Abstract: Cell lines (Supplementary Material 1), Primer sequences and Antibodies (Supplementary Material 2).
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361886324
